VPRIV®


 
 
 
 
 
 
 
 
 


 

VPRIV® (Velaglucerase alfa) is a long-term enzyme replacement therapy for patients with type 1 Gaucher disease.

VPRIV® is manufactured by Takeda.

Administration and Dosage:

VPRIV is administered every other week by intravenous infusion, which typically takes up to 60 minutes.

Common Side Effects:

The more common side effects of VPRIV® include hypersensitivity reactions, headache, dizziness, abdominal pain, nausea, back pain, joint pain, increased time it takes for blood to clot, tiredness/weakness, and fever.

More Information:

Please read the full Prescribing Information for VPRIV® and discuss any questions you have with your doctor.

Ready to Schedule an Appointment?

Please CLICK HERE to get started.

Indication:

VPRIV® is indicated to treat:

  • Type 1 Gaucher Disease